Free Trial

Leatt (OTCMKTS:LEAT) Shares Pass Above Fifty Day Moving Average - Should You Sell?

Leatt logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Technical breakout: Leatt's stock crossed above its 50‑day moving average of $9.11, trading as high as $9.25 (last trade $9.25) on volume of 2,180 shares, though it remains below its 200‑day MA of $9.91.
  • Recent financials and valuation: The micro‑cap has a market cap of $57.72M and a P/E of 18.14, reporting $0.08 EPS on $16.02M in quarterly revenue with a 7.94% ROE and 5.27% net margin.
  • Business profile: Leatt designs and manufactures protective sports gear—including the patented Leatt Brace®—for motocross, mountain biking and snow sports.
  • Five stocks we like better than Leatt.

Leatt Corp. (OTCMKTS:LEAT - Get Free Report)'s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $9.11 and traded as high as $9.25. Leatt shares last traded at $9.25, with a volume of 2,180 shares.

Leatt Price Performance

The firm has a market cap of $57.72 million, a price-to-earnings ratio of 18.14 and a beta of 0.80. The stock has a 50-day moving average of $9.11 and a 200-day moving average of $9.91.

Leatt (OTCMKTS:LEAT - Get Free Report) last issued its quarterly earnings results on Tuesday, March 24th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $16.02 million for the quarter. Leatt had a return on equity of 7.94% and a net margin of 5.27%.

Leatt Company Profile

(Get Free Report)

Leatt OTCMKTS: LEAT is a designer and manufacturer of protective sports gear, specializing in advanced safety equipment for high-impact activities such as motocross, mountain biking, and snow sports. The company's product portfolio includes the patented Leatt Brace® neck protection system, impact-absorbing body armor, full-face and off-road helmets, goggles, gloves, and riding apparel. These offerings are engineered to mitigate the risk of spinal and head injuries, combining biomechanical research with lightweight materials and user-focused design.

Founded by Dr.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Leatt Right Now?

Before you consider Leatt, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leatt wasn't on the list.

While Leatt currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines